A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.


BACKGROUND Small cell lung cancer (SCLC) is a chemotherapy-responsive tumor type but most patients ultimately experience disease progression. SCLC is associated with alterations in the coagulation system. The present randomized clinical trial (RCT) was designed to determine whether addition of low-molecular-weight heparin (LMWH) to combination chemotherapy… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.